Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TELA Bio, Inc. - Common stock (NQ:TELA)

1.580 -0.040 (-2.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TELA Bio, Inc. - Common stock

< Previous 1 2 3 4 5 6 Next >
TELA Bio to Announce Third Quarter 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repair
Study results show a low 2.6% recurrence rate and clinically meaningful improvement in patient quality of life 
From TELA Bio, Inc.
Via GlobeNewswire
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks. 
Via InvestorPlace
Recap: TELA Bio Q2 Earnings
  TELA Bio (NASDAQ:TELA) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:01 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows. 
Via Benzinga
TELA Bio: Q4 Earnings Insights
TELA Bio (NASDAQ:TELA) reported its Q4 earnings results on Monday, March 21, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings TELA Bio missed... 
Via Benzinga
Top Medical Specialties Stocks: Trading Opportunities For Next Week - Sunday, Oct. 2
A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some medical stock opportunities... 
Via Talk Markets
Over $2 Million Bet On Cassava Sciences; 4 Stocks Insiders Are Buying
Although US stocks closed mixed on Tuesday, there were a few notable insider trades. 
Via Benzinga
Earnings Preview For TELA Bio
  TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Analysts estimate that TELA Bio will... 
Via Benzinga
TELA Bio to Announce Second Quarter 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Insiders Buying Joby Aviation And 2 Other Stocks
Although US stocks closed lower on Friday, there were a few notable insider trades. 
Via Benzinga
Preview: TELA Bio's Earnings
TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
ROCE Insights For TELA Bio
In Q1, TELA Bio (NASDAQ:TELA) posted sales of $5.88 million. Earnings were up 7.74%, but TELA Bio still reported an overall loss of $7.27 million. In Q4, TELA Bio brought in $5.67... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 111 companies reached new 52-week lows. 
Via Benzinga
71 Biggest Movers From Yesterday
Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7... 
Via Benzinga
TELA Bio: Q1 Earnings Insights
TELA Bio (NASDAQ:TELA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings TELA Bio missed estimated earnings by... 
Via Benzinga
Zedge And 2 Other Stocks Insiders Are Buying
Although Dow Jones closed higher by around 500 points on Tuesday, there were a few notable insider trades. 
Via Benzinga
Earnings Scheduled For March 21, 2022
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •... 
Via Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
Via Benzinga
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. 
Via Benzinga
Insiders Buy Around $98M Of 3 Stocks
Although US stock futures traded lower this morning amid continued Russian bombing in Ukraine, there were a few notable insider trades. W... 
Via Benzinga
TELA Bio, Inc. (TELA) Q3 2021 Earnings Call Transcript
TELA earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
TELA Bio, Inc. (TELA) Q2 2021 Earnings Call Transcript
TELA earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
TELA Bio: Q2 Earnings Insights
Shares of TELA Bio (NASDAQ:TELA) decreased 2.3% after the company reported Q2 results. Quarterly Results Earnings per share decreased 7.55% over the past year to ($0.57), which... 
Via Benzinga
Earnings Outlook For TELA Bio
On Wednesday, August 11, TELA Bio (NASDAQ:TELA) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings, And Earnings... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers RAPT Therapeutics (NASDAQ:RAPT) s... 
Via Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
Earnings Scheduled For August 11, 2021
Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.